Lifevantage Corp — fact timeline

Lifevantage Corp reported the three months ended March 31, 2026 results: revenue $43.7 million, net income $1.4 million, EPS $0.11 per diluted share. Guidance lowered.

“For the third quarter ended March 31, 2026, the Company reported revenue of $43.7 million, a 25.2% decrease compared to revenue of $58.4 million in the third quarter of fiscal 2025. Revenue in the Americas region for the third quarter of fiscal 2026 decreased 28.9% primarily due to declines in sales of the MindBody GLP-1 System Ò , partially offset by sales of LoveBiome, which the Company acquired in October 2025. Revenue in the Asia/Pacific & Europe region decreased 7.7%; on a constant currency basis, revenue in the Asia/Pacific & Europe region decreased approximately 8.9%. Gross profit for the third quarter of fiscal 2026 was $34.5 million, or 79.0% of revenue, compared to $47.3 million, or 81.0% of revenue, for the same period in fiscal 2025. The decrease in gross profit as a percentage of revenue was primarily due to an allowance for inventory obsolescence related to the MindBody GLP-1 System Ò , along with increases in shipping and warehouse related expenses. Adjusted for the allo”

Lifevantage Corp: Eliminated the Certificate of Designation of Series A Junior Participating Preferred Stock, returning shares to authorized but undesignated preferred stock (effective 2024-11-18).

“On November 18, 2024, in connection with the expiration of the Rights Agreement described in Item 3.03 above, the Company filed a Certificate of Elimination of Series A Junior Participating Preferred Stock of LifeVantage Corporation (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware.”

Rajendran Anbalagan was appointed as Director at Lifevantage Corp.

“On August 26, 2024, the Board, based on the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Rajendran Anbalagan as a member of the Board, effective immediately.”

Erin Brockovich resigned as Director at Lifevantage Corp.

“On August 23, 2024, Erin Brockovich, a member of the Board of Directors (the “Board”) of LifeVantage Corporation (the “Company”), notified the Company of her resignation as a member of the Board and any committees of the Board, effective August 26, 2024.”

Lifevantage Corp reported three and nine months ended March 31, 2024 results: revenue $48.2 million, net income $1.7 million, EPS $0.13 per diluted share. Guidance lowered.

“health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: • Revenue of $48.2 million, a decrease of 10.2% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was down approximately 8.7%; • Revenue in”

Lifevantage Corp incurred revolving credit of $5,000,000 with Bank of America, N.A. at the greater of the Term SOFR Daily Floating Rate or 0.00%, plus 2.00% maturing April 12, 2027.

“The Loan Agreement provides for a revolving line of credit in aggregate principal amount not to exceed $5,000,000 (the "Line of Credit").”

Lifevantage Corp entered into Loan Agreement with Bank of America, N.A. valued at $5,000,000 (effective 2024-04-12).

“On April 12, 2024, LifeVantage Corporation (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Bank of America, N.A., as Lender (the “Lender”).”

Lifevantage Corp entered into Cooperation Agreement with the entities and persons listed on Exhibit A and Exhibit B (collectively, the Stockholder Parties) (effective 2024-02-14).

“LifeVantage Corporation (the “Company”) entered into a Cooperation Agreement (the “Agreement”) with the entities and persons listed on Exhibit A thereto (collectively, the “Radoff Parties”) and the entities and persons listed on Exhibit B thereto (collectively, the “Sudbury Parties,” and together with the Radoff Parties, the “Stockholder Parties”).”

Dayton Judd was appointed as Director at Lifevantage Corp.

“Effective as of February 14, 2024, Mr. Judd has been appointed as a member of the Board.”

Lifevantage Corp reported fiscal year 2024 results: revenue $207 million to $213 million, EPS $0.57 to $0.67.

“The Company expects to generate revenue in the range of $207 million to $213 million in fiscal year 2024, down from the previous range of $216 million to $226 million, and adjusted EBITDA of $16 million to $18 million, with adjusted earnings per share in the range of $0.57 to $0.67, up from the previous range of $0.52”

Lifevantage Corp reported second fiscal quarter ended December 31, 2023 results: revenue $51.6 million, net income $0.7 million, EPS $0.05 per diluted share.

“Second Quarter Fiscal 2024 Summary*: • Revenue of $51.6 million, a decrease of 3.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was down approximately 3.4%; • Revenue in the Americas decreased 1.6%, and revenue in Asia/Pacific & Europe decreased 10.0%. Excluding the negative impact of foreign currency fluctuations, second quarter revenue in Asia/Pacific & Europe decreased approximately 8.0%; • Net loss per diluted share was $0.05, versus net loss of $0.08 per diluted share a year ago; • Adjusted earnings per diluted share was $0.10, compared to adjusted loss per share of $0.07 a year ago; and • Adjusted EBITDA increased 289.0% to $3.1 million.”

Lifevantage Corp shareholders approved Ratification of the Adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent at the 2023-11-06 meeting.

“The Company’s stockholders ratified the adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent. Votes cast were as follows: For Against Abstain 4,651,264 4,120,670 403,355”

Lifevantage Corp shareholders approved Approval of an Amendment to the Company’s 2017 Long-Term Incentive Plan at the 2023-11-06 meeting.

“The Company’s stockholders approved an amendment to the Company’s 2017 Long-Term Incentive Plan. Votes cast were as follows: For Against Abstain 5,893,009 2,812,877 469,403”

Lifevantage Corp shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-11-06 meeting.

“The Company’s stockholders ratified the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024. Votes cast were as follows: For Against Abstain 8,690,892 36,853 529,496”

Lifevantage Corp shareholders approved Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company’s Named Executive Officers at the 2023-11-06 meeting.

“The Company’s stockholders approved, on an advisory basis, a resolution approving the compensation of the Company’s named executive officers. Votes cast were as follows: For Against Abstain 5,937,422 2,871,303 366,563”

Lifevantage Corp shareholders approved Election of Directors at the 2023-11-06 meeting.

“The Company’s stockholders elected Michael A. Beindorff, Erin Brockovich, Steven R. Fife, Raymond B. Greer, Cynthia Latham, Darwin K. Lewis and Garry Mauro as directors, each to hold office until the Company’s fiscal year 2025 annual meeting of stockholders or until his or her respective successor is elected and qualified. Votes cast were as follows: Company nominees : For Withhold Mr. Michael A. Beindorff 5,829,222 3,345,850 Ms. Erin Brockovich 8,180,791 671,206 Mr. Steven R. Fife 8,236,727 615,271 Mr. Raymond B. Greer 8,170,090 681,907 Ms. Cynthia Latham 8,259,106 592,891 Mr. Darwin K. Lewis 6,081,144 3,093,928 Mr. Garry Mauro 4,614,789 4,560,287 Nominees of Bradley L. Radoff and Sudbury Capital Fund, LP, and certain of their affiliates and other participants in their proxy solicitation : For Withhold Mr. Dayton Judd 4,533,852 4,601,273 Mr. Michael Lohner 3,290,058 5,845,067 Mr. Bradley L. Radoff 3,064,056 6,071,069”

Lifevantage Corp reported the first fiscal quarter ended September 30, 2023 results: revenue $51.4 million, net income $0.6 million, EPS $0.05 per diluted share.

“to activate optimal health processes, today reported financial results for its first fiscal quarter ended September 30, 2023. First Quarter Fiscal 2024 Summary*: • Revenue of $51.4 million, a decrease of 0.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 0.2%; • Revenue in”

Lifevantage Corp shareholders approved Ratification of the Adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent at the 2023-11-06 meeting.

“Proposal 5 – Ratification of the Adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent. The estimated preliminary votes for the ratification of the adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent, were as follows: For Against Abstain 4,651,264 4,120,670 403,355”

Lifevantage Corp shareholders approved Approval of an Amendment to the Company's 2017 Long-Term Incentive Plan at the 2023-11-06 meeting.

“Proposal 4 – Approval of an Amendment to the Company’s 2017 Long-Term Incentive Plan. The estimated preliminary votes to approve an amendment to the Company’s 2017 Long-Term Incentive Plan were as follows: For Against Abstain 5,893,009 2,812,877 469,403”

Lifevantage Corp shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-11-06 meeting.

“Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm. The estimated preliminary votes for the ratification of the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024 were as follows: For Against Abstain 8,690,892 36,853 529,496”

Lifevantage Corp shareholders approved Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company's Named Executive Officers at the 2023-11-06 meeting.

“Proposal 2 – Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company’s Named Executive Officers . The estimated preliminary votes for the approval, on an advisory basis, of a resolution approving the compensation of the Company’s named executive officers were as follows: For Against Abstain 5,937,422 2,871,303 366,563”

Lifevantage Corp shareholders approved Election of Directors at the 2023-11-06 meeting.

“Proposal 1 – Election of Directors . The estimated preliminary votes for each director nominee are set forth below: Company nominees : For Withhold Mr. Michael A. Beindorff 5,829,222 3,345,850 Ms. Erin Brockovich 8,180,791 671,206 Mr. Steven R. Fife 8,236,727 615,271 Mr. Raymond B. Greer 8,170,090 681,907 Ms. Cynthia Latham 8,259,106 592,891 Mr. Darwin K. Lewis 6,081,144 3,093,928 Mr. Garry Mauro 4,614,789 4,560,287 Nominees of Bradley L. Radoff and Sudbury Capital Fund, LP, and certain of their affiliates and other participants in their proxy solicitation : For Withhold Mr. Dayton Judd 4,533,852 4,601,273 Mr. Michael Lohner 3,290,058 5,845,067 Mr. Bradley L. Radoff 3,064,056 6,071,069”

Lifevantage Corp: Adopted Certificate of Designation of Series A Junior Participating Preferred Stock (effective 2023-08-30).

“The Certificate of Designation was filed with the Secretary of State of the State of Delaware on August 30, 2023.”

Lifevantage Corp reported fourth quarter ended June 30, 2023 results: revenue $54.2 million, net income $2.0 million, EPS $0.15 per diluted share.

“optimal health processes, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2023. Fourth Quarter Fiscal 2023 Summary*: • Revenue of $54.2 million, an increase of 6.4% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was up approximately 7.8%; • Revenue in”

Lifevantage Corp reported third fiscal quarter ended March 31, 2023 results: revenue $53.7 million, net income $1.0 million, EPS $0.08 per diluted share. Guidance reaffirmed.

“, LifeVantage Corporation (Nas daq: LFVN) today reported financial results for its third fiscal quarter ended March 31, 2023. Third Quarter Fiscal 2023 Summary*: • Revenue of $53.7 million, an increase of 7.5% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was up approximately 10.4%; • Revenue in”

Lifevantage Corp engaged Deloitte & Touch LLP as its auditor.

“On April 13, 2023, the Audit Committee of the Board of Directors (the “Audit Committee”) of LifeVantage Corporation (the “Company”) engaged Deloitte & Touch LLP (“Deloitte”) as the Company’s new independent registered public accounting firm, effective immediately.”

Matt Cooley resigned as Chief Operating Officer at Lifevantage Corp.

“On March 20, 2023, LifeVantage Corporation (the “Company”) received notice from Chief Operating Officer Matt Cooley of his voluntary resignation from the Company.”

Lifevantage Corp reported three and six months ended December 31, 2022 results: revenue $53.7 million. Guidance reaffirmed.

“LifeVantage Corporation (Nas daq: LFVN) today reported financial results for its second fiscal quarter ended December 31, 2022. Second Quarter Fiscal 2023 Summary*: • Revenue of $53.7 million, an increase of 2.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was up approximately 7.4%; • Revenue in”

Lifevantage Corp shareholders approved To approve an amendment to the 2017 Long-Term Incentive Plan at the 2022-11-10 meeting.

“Proposal 4 – Approval of an Amendment to the 2017 Long Term Incentive Plan: : The Company’s stockholders approved the amendment to the 2017 Long-Term Incentive Plan. Votes cast were as follows: For Against Abstain Broker Non Votes 3,471,779 575,564 20,236 4,301,471”

Lifevantage Corp shareholders approved To ratify the selection of WSRP, LLC as the Company's independent registered public accounting firm for the Company's fiscal year ending June 30, 2023 at the 2022-11-10 meeting.

“Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm : The Company’s stockholders ratified the selection of WSRP, LLC as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2023. Votes cast were as follows: For Against Abstain 7,940,835 103,034 325,181”

Lifevantage Corp shareholders approved To approve, on an advisory basis, a resolution approving the compensation of the Company's named executive officers at the 2022-11-10 meeting.

“Proposal 2 – Approval of Compensation of the Company’s Named Executive Officers . The Company’s stockholders approved, on an advisory and non-binding basis, the compensation of the Company’s named executive officers. Votes cast were as follows: For Against Abstain Broker Non-Votes 3,388,050 659,309 20,220 4,301,471”

Lifevantage Corp shareholders approved To elect the following seven director nominees to the Company's board of directors to hold office until the Company's fiscal 2024 annual meeting of stockholders or until their respective successors are elected and qualified at the 2022-11-10 meeting.

“Proposal 1 – Election of Directors : The Company’s stockholders elected each of the seven director nominees listed above to the Company’s board of directors to serve until the Company’s fiscal 2024 annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows: For Against Abstain Broker Non-Votes Mr. Michael A. Beindorff 3,663,777 390,841 12,961 4,301,471 Ms. Erin Brockovich 3,467,258 583,089 17,232 4,301,471 Mr. Steven R. Fife 3,666,300 392,432 8,847 4,301,471 Mr. Raymond B. Greer 3,569,953 479,076 18,550 4,301,471 Ms. Cynthia Latham 3,727,975 327,370 12,234 4,301,471 Mr. Darwin K. Lewis 3,796,342 246,155 25,082 4,301,471 Mr. Garry Mauro 3,476,604 582,198 8,777 4,301,471”

Lifevantage Corp shareholders approved Approval of an amendment to the 2017 Long-Term Incentive Plan. at the 2022-11-10 meeting.

“Proposal 4 – Approval of an Amendment to the 2017 Long Term Incentive Plan: : The Company’s stockholders approved the amendment to the 2017 Long-Term Incentive Plan. Votes cast were as follows: For Against Abstain Broker Non Votes 3,471,779 575,564 20,236 4,301,471”

Lifevantage Corp shareholders approved Ratification of the selection of WSRP, LLC as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2023. at the 2022-11-10 meeting.

“Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm : The Company’s stockholders ratified the selection of WSRP, LLC as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2022. Votes cast were as follows: For Against Abstain 7,940,835 103,034 325,181”

Lifevantage Corp shareholders approved Advisory approval of the compensation of the Company’s named executive officers. at the 2022-11-10 meeting.

“Proposal 2 – Approval of Compensation of the Company’s Named Executive Officers . The Company’s stockholders approved, on an advisory and non-binding basis, the compensation of the Company’s named executive officers. Votes cast were as follows: For Against Abstain Broker Non-Votes 3,388,050 659,309 20,220 4,301,471”

Lifevantage Corp shareholders approved Election of seven director nominees to the board of directors to hold office until the fiscal 2023 annual meeting. at the 2022-11-10 meeting.

“Proposal 1 – Election of Directors : The Company’s stockholders elected each of the six director nominees listed above to the Company’s board of directors to serve until the Company’s fiscal 2022 annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows: For Against Abstain Broker Non-Votes Mr. Michael A. Beindorff 3,663,777 390,841 12,961 4,301,471 Ms. Erin Brockovich 3,467,258 583,089 17,232 4,301,471 Mr. Steven R. Fife 3,666,300 392,432 8,847 4,301,471 Mr. Raymond B. Greer 3,569,953 479,076 18,550 4,301,471 Ms. Cynthia Latham 3,727,975 327,370 12,234 4,301,471 Mr. Darwin K. Lewis 3,796,342 246,155 25,082 4,301,471 Mr. Garry Mauro 3,476,604 582,198 8,777 4,301,471”

Lifevantage Corp reported fiscal year 2023 results: revenue range of $200 million to $212 million, EPS range of $0.27 to $0.39. Guidance reaffirmed.

“2022 to all stockholders of record at the close of business on December 1, 2022. Fiscal Year 2023 Guidance The Company continues to expect to generate revenue in the range of $200 million to $212 million in fiscal year 2023 and adjusted EBITDA of $12 million to $14 million, with adjusted earnings per share in the range of $0.27 to $0.39, which assumes a full year”

Lifevantage Corp reported the first fiscal quarter ended September 30, 2022 results: revenue $51.8 million, net income $0.6 million, or $0.05 per diluted share, EPS $0.05 per diluted share. Guidance reaffirmed.

“LifeVantage Corporation (Nas daq: LFVN) today reported financial results for its first fiscal quarter ended September 30, 2022. First Quarter Fiscal 2023 Summary*: • Revenue of $51.8 million, a decrease of 2.7% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was up approximately 2.3%; • Revenue in the”

Justin Rose departed as Chief Sales Officer at Lifevantage Corp.

“The employment of Justin Rose, LifeVantage Corporation’s Chief Sales Officer, ended effective on March 7, 2022.”

Cynthia Latham was appointed as Director at Lifevantage Corp.

“the appointment of Cynthia Latham as a member of the Board”

Steven R. Fife changed role as Chief Financial Officer at Lifevantage Corp.

“Steven R. Fife will step down from his role as the Company’s Chief Financial Officer effective immediately.”

Carl Aure was appointed as Chief Financial Officer at Lifevantage Corp.

“On October 25, 2021, the Company announced the appointment of Carl Aure as its Chief Financial Officer, effective immediately.”

Vinayak Hegde departed as Director at Lifevantage Corp.

“On August 12, 2021, Vinayak Hegde, a member of the Board of Directors (the “Board”) of LifeVantage Corporation (the “Company”), informed the Company that, due to his other commitments, he has decided not to stand for re-election as a director of the Company at the fiscal 2022 annual meeting of stockholders expected to be held on or about November 11, 2021.”